CIK 0002019410
- Non-accelerated filer
- Emerging growth company
Caris Life Sciences, Inc.
Sign in to watch- Ticker
- CAI
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- Operating
- EIN
- 852077369
- Phone
- +1 866-771-8946
- Business address
- 750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $27,204,813
- in 3 filings
Net −$27,204,813. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | HALBERT JON Director | Grant or award | +13,192 | 131,813 | ||
| 2026-05-15 | HALBERT JON Director | Purchase | +68,000 | $14.56 | $990K | 704,598 |
| 2026-02-26 | HALBERT JON Director | Grant or award | +2,492 | $20.06 | $50K | 118,621 |
| 2025-06-20 | HALBERT JON Director | Conversion | +1,250,000 | 1,250,000 | ||
| 2025-06-20 | HALBERT JON Director | Conversion · Series A Preferred Stock | −5,000,000 | 0 | ||
| 2025-02-27 | HALBERT JON Director | Grant or award | +16,129 | 116,129 |
Page 1 of 1 · 6 trades